Evaluation of toxicity of surgery and/or chemoirradiation treatment of uterine cervix cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-02

AUTHORS

Vicente Tormo Ferrero, Francisco J. Andreu Martínez, Rafael Cardenal Maciá

ABSTRACT

OBJECTIVE: To evaluate acute and chronic toxicity of chemoirradiation treatment (neoadjuvant, adjuvant and radical treatment) in patients diagnosed with cervix cancer. METHODS: From December 1999 to August 2007, 53 patients diagnosed with adenocarcinoma or squamous cell carcinoma of the uterine cervix received neoadjuvant, adjuvant or radical chemoirradiation. RESULTS: Acute gastrointestinal toxicity of grade 3 or more in 9 patients (17%) and haematological toxicity of grade 3 or more in 9 patients (17%). Chronic toxicity of grade 3 or more was shown in only 2 patients (4%). The most frequent toxicities were gastrointestinal toxicity and haematological toxicity. The most frequent chronic toxicities were gastrointestinal toxicity and vaginal toxicity. CONCLUSIONS: We report that the combined neoadjuvant, adjuvant or radical chemoirradiation treatment with weekly cisplatin chemotherapy (40 mg/m(2)/week) in patients diagnosed with cervix cancer is a well tolerated treatment and chronic and acute toxicity is low-grade. This treatment scheme has easy compliance. More... »

PAGES

109-113

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12094-009-0323-0

DOI

http://dx.doi.org/10.1007/s12094-009-0323-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027705134

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19211377


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Squamous Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uterine Cervical Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Servicio de Oncolog\u00eda Radioter\u00e1pica, Hospital Universitari Sant Joan d\u2019Alacant, Crta. Ncal. 332 Alicante-Valencia, s/n, ES-03550, Sant Joan d\u2019Alacant, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferrero", 
        "givenName": "Vicente Tormo", 
        "id": "sg:person.012720576216.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012720576216.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Servicio de Oncolog\u00eda Radioter\u00e1pica, Hospital Universitari Sant Joan d\u2019Alacant, Crta. Ncal. 332 Alicante-Valencia, s/n, ES-03550, Sant Joan d\u2019Alacant, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mart\u00ednez", 
        "givenName": "Francisco J. Andreu", 
        "id": "sg:person.010670445215.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010670445215.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Servicio de Oncolog\u00eda Radioter\u00e1pica, Hospital Universitari Sant Joan d\u2019Alacant, Crta. Ncal. 332 Alicante-Valencia, s/n, ES-03550, Sant Joan d\u2019Alacant, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maci\u00e1", 
        "givenName": "Rafael Cardenal", 
        "id": "sg:person.011566424025.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011566424025.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejm199904153401503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008808206"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.07.197", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009603066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/14651858.cd002225", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022307448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.00.0497", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028032457"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199904153401501", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036650987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1034/j.1600-0412.2000.0790121093.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041042804"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199904153401502", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049654304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/clon.2002.0076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052560890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.20.4.966", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202832"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/00016340009169270", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070975211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.5.1339", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074460850"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-02", 
    "datePublishedReg": "2009-02-01", 
    "description": "OBJECTIVE: To evaluate acute and chronic toxicity of chemoirradiation treatment (neoadjuvant, adjuvant and radical treatment) in patients diagnosed with cervix cancer.\nMETHODS: From December 1999 to August 2007, 53 patients diagnosed with adenocarcinoma or squamous cell carcinoma of the uterine cervix received neoadjuvant, adjuvant or radical chemoirradiation.\nRESULTS: Acute gastrointestinal toxicity of grade 3 or more in 9 patients (17%) and haematological toxicity of grade 3 or more in 9 patients (17%). Chronic toxicity of grade 3 or more was shown in only 2 patients (4%). The most frequent toxicities were gastrointestinal toxicity and haematological toxicity. The most frequent chronic toxicities were gastrointestinal toxicity and vaginal toxicity.\nCONCLUSIONS: We report that the combined neoadjuvant, adjuvant or radical chemoirradiation treatment with weekly cisplatin chemotherapy (40 mg/m(2)/week) in patients diagnosed with cervix cancer is a well tolerated treatment and chronic and acute toxicity is low-grade. This treatment scheme has easy compliance.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12094-009-0323-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1035367", 
        "issn": [
          "1699-048X", 
          "1699-3055"
        ], 
        "name": "Clinical and Translational Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "name": "Evaluation of toxicity of surgery and/or chemoirradiation treatment of uterine cervix cancer", 
    "pagination": "109-113", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "83fb5c6c447669ee99a0c242a260a724a7b3fc36e6839cdc7aa3a07babac7c1d"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19211377"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101247119"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12094-009-0323-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027705134"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12094-009-0323-0", 
      "https://app.dimensions.ai/details/publication/pub.1027705134"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000522.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs12094-009-0323-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12094-009-0323-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12094-009-0323-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12094-009-0323-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12094-009-0323-0'


 

This table displays all metadata directly associated to this object as RDF triples.

172 TRIPLES      21 PREDICATES      54 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12094-009-0323-0 schema:about N15ad743ed20a4e88946222ea7ccc3e3f
2 N24b187efcd77464ea9adb332960e9b5d
3 N261b0c5c8faa4d638e8f6e81341c77c5
4 N38d0338491a04d689a9f39fb3c35ed81
5 N3a57bd50e93445cd878b5ec72e0ced19
6 N439d702264f8406499bb4a989438c89b
7 N4ce0a535ad424bda91de5c0be4c87573
8 N5b7f2509329945c4b28239211dfb5129
9 N7024e4a88b704e758c805757da6bc3e4
10 N7813be5bdc5645daa107d1b6e669ed31
11 N82bb81284ed14794a84604d2f5803684
12 N841d32bdb88b462688c2a55f9f8798cf
13 Nd4c7fc9c1acd4bdebd950b1a1ea2afde
14 Nede67d219c534fd19519ce08b0ededde
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author N5ad771d82216451baf130cf66eb1fac5
18 schema:citation https://doi.org/10.1002/14651858.cd002225
19 https://doi.org/10.1034/j.1600-0412.2000.0790121093.x
20 https://doi.org/10.1053/clon.2002.0076
21 https://doi.org/10.1056/nejm199904153401501
22 https://doi.org/10.1056/nejm199904153401502
23 https://doi.org/10.1056/nejm199904153401503
24 https://doi.org/10.1200/jco.1999.17.5.1339
25 https://doi.org/10.1200/jco.20.4.966
26 https://doi.org/10.1200/jco.2004.00.0497
27 https://doi.org/10.1200/jco.2004.07.197
28 https://doi.org/10.3109/00016340009169270
29 schema:datePublished 2009-02
30 schema:datePublishedReg 2009-02-01
31 schema:description OBJECTIVE: To evaluate acute and chronic toxicity of chemoirradiation treatment (neoadjuvant, adjuvant and radical treatment) in patients diagnosed with cervix cancer. METHODS: From December 1999 to August 2007, 53 patients diagnosed with adenocarcinoma or squamous cell carcinoma of the uterine cervix received neoadjuvant, adjuvant or radical chemoirradiation. RESULTS: Acute gastrointestinal toxicity of grade 3 or more in 9 patients (17%) and haematological toxicity of grade 3 or more in 9 patients (17%). Chronic toxicity of grade 3 or more was shown in only 2 patients (4%). The most frequent toxicities were gastrointestinal toxicity and haematological toxicity. The most frequent chronic toxicities were gastrointestinal toxicity and vaginal toxicity. CONCLUSIONS: We report that the combined neoadjuvant, adjuvant or radical chemoirradiation treatment with weekly cisplatin chemotherapy (40 mg/m(2)/week) in patients diagnosed with cervix cancer is a well tolerated treatment and chronic and acute toxicity is low-grade. This treatment scheme has easy compliance.
32 schema:genre research_article
33 schema:inLanguage en
34 schema:isAccessibleForFree false
35 schema:isPartOf N2b988923f6604286ac78d9a8a92e8702
36 Nf70067839bf2488f9a67efc970f5b479
37 sg:journal.1035367
38 schema:name Evaluation of toxicity of surgery and/or chemoirradiation treatment of uterine cervix cancer
39 schema:pagination 109-113
40 schema:productId N3ca9dc7d431d4c72bcd7c0b5ea9cfc18
41 N45d9c3bf73db4483b8eb1fd5700832fd
42 N5f1b3eb9ad724751a182c32f87e9c7ff
43 N9718e8729d9e417b98d68b9abeafc1d1
44 Ndde1a61b109b46519cf9170b47979aa7
45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027705134
46 https://doi.org/10.1007/s12094-009-0323-0
47 schema:sdDatePublished 2019-04-10T18:22
48 schema:sdLicense https://scigraph.springernature.com/explorer/license/
49 schema:sdPublisher Nc7b94dbefa874b708458a5eb48868aae
50 schema:url http://link.springer.com/10.1007%2Fs12094-009-0323-0
51 sgo:license sg:explorer/license/
52 sgo:sdDataset articles
53 rdf:type schema:ScholarlyArticle
54 N15ad743ed20a4e88946222ea7ccc3e3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
55 schema:name Adenocarcinoma
56 rdf:type schema:DefinedTerm
57 N24b187efcd77464ea9adb332960e9b5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
58 schema:name Uterine Cervical Neoplasms
59 rdf:type schema:DefinedTerm
60 N261b0c5c8faa4d638e8f6e81341c77c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Adult
62 rdf:type schema:DefinedTerm
63 N2b988923f6604286ac78d9a8a92e8702 schema:volumeNumber 11
64 rdf:type schema:PublicationVolume
65 N38d0338491a04d689a9f39fb3c35ed81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Humans
67 rdf:type schema:DefinedTerm
68 N3a57bd50e93445cd878b5ec72e0ced19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Neoadjuvant Therapy
70 rdf:type schema:DefinedTerm
71 N3a5fac0b7662478684d9f151e83005e6 rdf:first sg:person.010670445215.05
72 rdf:rest Na98309b524e6419099760979dd941a47
73 N3ca9dc7d431d4c72bcd7c0b5ea9cfc18 schema:name nlm_unique_id
74 schema:value 101247119
75 rdf:type schema:PropertyValue
76 N439d702264f8406499bb4a989438c89b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Follow-Up Studies
78 rdf:type schema:DefinedTerm
79 N45d9c3bf73db4483b8eb1fd5700832fd schema:name dimensions_id
80 schema:value pub.1027705134
81 rdf:type schema:PropertyValue
82 N4ce0a535ad424bda91de5c0be4c87573 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Carcinoma, Squamous Cell
84 rdf:type schema:DefinedTerm
85 N5ad771d82216451baf130cf66eb1fac5 rdf:first sg:person.012720576216.16
86 rdf:rest N3a5fac0b7662478684d9f151e83005e6
87 N5b7f2509329945c4b28239211dfb5129 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Combined Modality Therapy
89 rdf:type schema:DefinedTerm
90 N5f1b3eb9ad724751a182c32f87e9c7ff schema:name pubmed_id
91 schema:value 19211377
92 rdf:type schema:PropertyValue
93 N7024e4a88b704e758c805757da6bc3e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Female
95 rdf:type schema:DefinedTerm
96 N7813be5bdc5645daa107d1b6e669ed31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Middle Aged
98 rdf:type schema:DefinedTerm
99 N82bb81284ed14794a84604d2f5803684 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Antineoplastic Combined Chemotherapy Protocols
101 rdf:type schema:DefinedTerm
102 N841d32bdb88b462688c2a55f9f8798cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Retrospective Studies
104 rdf:type schema:DefinedTerm
105 N9718e8729d9e417b98d68b9abeafc1d1 schema:name doi
106 schema:value 10.1007/s12094-009-0323-0
107 rdf:type schema:PropertyValue
108 Na98309b524e6419099760979dd941a47 rdf:first sg:person.011566424025.18
109 rdf:rest rdf:nil
110 Nc7b94dbefa874b708458a5eb48868aae schema:name Springer Nature - SN SciGraph project
111 rdf:type schema:Organization
112 Nd4c7fc9c1acd4bdebd950b1a1ea2afde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Radiotherapy
114 rdf:type schema:DefinedTerm
115 Ndde1a61b109b46519cf9170b47979aa7 schema:name readcube_id
116 schema:value 83fb5c6c447669ee99a0c242a260a724a7b3fc36e6839cdc7aa3a07babac7c1d
117 rdf:type schema:PropertyValue
118 Nede67d219c534fd19519ce08b0ededde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Aged
120 rdf:type schema:DefinedTerm
121 Nf70067839bf2488f9a67efc970f5b479 schema:issueNumber 2
122 rdf:type schema:PublicationIssue
123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
124 schema:name Medical and Health Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
127 schema:name Oncology and Carcinogenesis
128 rdf:type schema:DefinedTerm
129 sg:journal.1035367 schema:issn 1699-048X
130 1699-3055
131 schema:name Clinical and Translational Oncology
132 rdf:type schema:Periodical
133 sg:person.010670445215.05 schema:affiliation https://www.grid.ac/institutes/grid.411263.3
134 schema:familyName Martínez
135 schema:givenName Francisco J. Andreu
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010670445215.05
137 rdf:type schema:Person
138 sg:person.011566424025.18 schema:affiliation https://www.grid.ac/institutes/grid.411263.3
139 schema:familyName Maciá
140 schema:givenName Rafael Cardenal
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011566424025.18
142 rdf:type schema:Person
143 sg:person.012720576216.16 schema:affiliation https://www.grid.ac/institutes/grid.411263.3
144 schema:familyName Ferrero
145 schema:givenName Vicente Tormo
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012720576216.16
147 rdf:type schema:Person
148 https://doi.org/10.1002/14651858.cd002225 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022307448
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1034/j.1600-0412.2000.0790121093.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041042804
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1053/clon.2002.0076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052560890
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1056/nejm199904153401501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036650987
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1056/nejm199904153401502 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049654304
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1056/nejm199904153401503 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008808206
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1200/jco.1999.17.5.1339 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074460850
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1200/jco.20.4.966 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202832
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1200/jco.2004.00.0497 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028032457
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1200/jco.2004.07.197 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009603066
167 rdf:type schema:CreativeWork
168 https://doi.org/10.3109/00016340009169270 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070975211
169 rdf:type schema:CreativeWork
170 https://www.grid.ac/institutes/grid.411263.3 schema:alternateName Hospital Universitari Sant Joan D'Alacant
171 schema:name Servicio de Oncología Radioterápica, Hospital Universitari Sant Joan d’Alacant, Crta. Ncal. 332 Alicante-Valencia, s/n, ES-03550, Sant Joan d’Alacant, Alicante, Spain
172 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...